BHS Vaccine Centers Phasing Out Johnson & Johnson

Print Story | Email Story
PITTSFIELD, Mass — Following guidance from the federal Centers for Disease Control (CDC), Berkshire Health Systems will discontinue widespread distribution of the Johnson & Johnson (J&J) COVID-19 vaccines and boosters at its testing and vaccine centers, effective Jan. 6, 2022.
 
"This decision is based on guidance from the CDC, which recently examined the efficacy, safety, and supply of the J&J vaccine," said James Lederer, MD, BHS Chief Medical Officer/Chief Quality Officer.
 
"In light of these recommendations, the CDC has made it clear that getting any vaccine is far better than remaining unvaccinated. Any patient who would like to request an initial or booster dose of the J&J vaccine, despite known limitations and risks, can call the COVID-19 Hotline to consult with a provider," he explained.
 
Anyone who is currently scheduled for a J&J vaccine or booster at a BHS Testing and Vaccine Center on or before Jan 5 will have the option to receive the J&J vaccine as scheduled or can receive a Pfizer or Moderna dose instead.
 
"For individuals who have received one shot of the J&J vaccine, we highly recommend getting a Pfizer or Moderna booster. If they have already received a J&J booster, we are asking them to talk to their primary care provider about receiving a booster dose of one of the other available vaccines," said Dr. Lederer.
 
The BHS COVID-19 hotline is 855-BMC-LINK (855-262-5465). For more information on the CDC's decision, please visit their website: https://www.cdc.gov/media/releases/2021/s1216-covid-19-vaccines.html

Tags: BHS,   BMC,   COVID-19,   vaccinations,   


More Coronavirus Updates

Keep up to date on the latest COVID-19 news:


If you would like to contribute information on this article, contact us at info@iberkshires.com.

Dalton Board Signs Off on Land Sale Over Residents' Objections

By Sabrina DammsiBerkshires Staff

Residents demanded the right to speak but the agenda did not include public comment. Amy Musante holds a sign saying the town now as '$20,000 less for a police station.'
DALTON, Mass. — The Select Board signed the sale on the last of what had been known as the Bardin property Monday even as a handful of residents demanded the right to speak against the action. 
 
The quitclaim deed transfers the nine acres to Thomas and Esther Balardini, who purchased the two other parcels in Dalton. They were the third-highest bidders at $31,500. Despite this, the board awarded them the land in an effort to keep the property intact.
 
"It's going to be an ongoing battle but one I think that has to be fought [because of] the disregard for the taxpayers," said Dicken Crane, the high bidder at $51,510.
 
"If it was personal I would let it go, but this affects everyone and backing down is not in my nature." 
 
Crane had appealed to the board to accept his bid during two previous meetings. He and others opposed to accepting the lower bid say it cost the town $20,000. After the meeting, Crane said he will be filing a lawsuit and has a citizen's petition for the next town meeting with over 100 signatures. 
 
Three members of the board — Chair Robert Bishop Jr., John Boyle, and Marc Strout — attended the 10-minute meeting. Members Anthony Pagliarulo and Daniel Esko previously expressed their disapproval of the sale to the Balardinis. 
 
Pagliarulo voted against the sale but did sign the purchase-and-sale agreement earlier this month. His reasoning was the explanation by the town attorney during an executive session that, unlike procurement, where the board is required to accept the lowest bid for services, it does have some discretion when it comes to accepting bids in this instance.
 
View Full Story

More Pittsfield Stories